Neuroimmune Mechanisms in Signaling of Pain During Acute Kidney Injury (AKI)
Acute kidney injury (AKI) is a significant global health concern. The primary causes of AKI include ischemia, sepsis and nephrotoxicity. The unraveled interface between nervous system and immune response with specific focus on pain pathways is generating a huge interest in reference to AKI. The nerv...
Saved in:
Published in | Frontiers in medicine Vol. 7; p. 424 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
07.08.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Acute kidney injury (AKI) is a significant global health concern. The primary causes of AKI include ischemia, sepsis and nephrotoxicity. The unraveled interface between nervous system and immune response with specific focus on pain pathways is generating a huge interest in reference to AKI. The nervous system though static executes functions by nerve fibers throughout the body. Neuronal peptides released by nerves effect the immune response to mediate the hemodynamic system critical to the functioning of kidney. Pain is the outcome of cellular cross talk between nervous and immune systems. The widespread release of neuropeptides, neurotransmitters and immune cells contribute to bidirectional neuroimmune cross talks for pain manifestation. Recently, we have reported pain pathway genes that may pave the way to better understand such processes during AKI. An auxiliary understanding of the functions and communications in these systems will lead to novel approaches in pain management and treatment through the pathological state, specifically during acute kidney injury. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Edited by: Kedra Wallace, University of Mississippi Medical Center, United States This article was submitted to Nephrology, a section of the journal Frontiers in Medicine Reviewed by: Gurvinder Kaur, Laboratory Oncology, All India Institute of Medical Sciences, India; Sal Harwani, University of Iowa, United States |
ISSN: | 2296-858X 2296-858X |
DOI: | 10.3389/fmed.2020.00424 |